Literature DB >> 1374023

Lung cytokine production in bleomycin-induced pulmonary fibrosis.

S H Phan1, S L Kunkel.   

Abstract

In bleomycin-induced pulmonary fibrosis, lung injury is accompanied with inflammation and subsequent fibrosis. In this study, lung mRNA for several cytokines was measured in bleomycin-treated mice to evaluate their roles in lung fibrosis. Significant increases in tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) mRNA were found in lungs of bleomycin-treated responder CBA mice but not in nonresponder BALB/c mice. Increases in responder animals peaked on day 7 after bleomycin administration, and subsequently returned toward control levels. This time course paralleled that for the increase in beta-actin mRNA, but preceded the peak increase in mRNA for collagens I and III. When lung macrophages were analyzed for cytokine secretion, differences were observed between alveolar macrophages and interstitial cells, and between cells from bleomycin-responsive CBA and nonresponsive BALB/c mice. Only alveolar macrophages from CBA mice secreted increased amounts of IL-1. TNF-alpha activity was increased in conditioned media of alveolar and interstitial cells of CBA mice, while only alveolar macrophages of nonresponder BALB/c mice secreted any activity. The kinetics of the increased secretion of TNF-alpha was dissimilar for these different cells. These results are consistent with the conclusion that increased production of TNF-alpha and TGF-beta is an important component of the fibrotic process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374023     DOI: 10.3109/01902149209020649

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  74 in total

1.  Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.

Authors:  M Kolb; P J Margetts; D C Anthony; F Pitossi; J Gauldie
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice.

Authors:  S Yara; K Kawakami; N Kudeken; M Tohyama; K Teruya; T Chinen; A Awaya; A Saito
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

3.  SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

Authors:  Sabina Sangaletti; Claudio Tripodo; Barbara Cappetti; Patrizia Casalini; Claudia Chiodoni; Silvia Piconese; Alessandra Santangelo; Mariella Parenza; Ivano Arioli; Silvia Miotti; Mario P Colombo
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

4.  Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury.

Authors:  Min He; Ni Cheng; Wei-wei Gao; Meng Zhang; Yue-yun Zhang; Richard D Ye; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

5.  Pulmonary platelet trapping induced by bleomycin: correlation with fibrosis and involvement of the beta 2 integrins.

Authors:  P F Piguet; C Vesin
Journal:  Int J Exp Pathol       Date:  1994-10       Impact factor: 1.925

6.  IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

Authors:  Pamela Gasse; Caroline Mary; Isabelle Guenon; Nicolas Noulin; Sabine Charron; Silvia Schnyder-Candrian; Bruno Schnyder; Shizuo Akira; Valérie F J Quesniaux; Vincent Lagente; Bernhard Ryffel; Isabelle Couillin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

8.  Enhanced type III collagen gene expression during bleomycin induced lung fibrosis.

Authors:  S Shahzeidi; B Mulier; B de Crombrugghe; P K Jeffery; R J McAnulty; G J Laurent
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

9.  Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis.

Authors:  K Zhang; K C Flanders; S H Phan
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 10.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.